Previous close | 0.8800 |
Open | 0.8500 |
Bid | 0.8700 |
Ask | 1.0200 |
Strike | 37.50 |
Expiry date | 2026-01-16 |
Day's range | 0.8500 - 0.8800 |
Contract range | N/A |
Volume | |
Open interest | 828 |
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.
Q1 2024 Gilead Sciences Inc Earnings Call